University Of Wisconsin, Madison

This early-stage trial tested a combination of an experimental fusion protein (hu14.18-IL2), radiation, and two immunotherapy drugs (nivolumab and ipilimumab) in people with advanced melanoma that couldn't be surgically removed. The goal was to find the safest dose and check for …

This study tested a special type of radiation (pulse reduced dose rate) combined with the drug bevacizumab in 49 people with recurrent high-grade gliomas (brain tumors). The goal was to see if this combination could help patients live longer. Participants received radiation over …

This study looked at whether psilocybin, a psychedelic drug, is safe and practical to use alongside behavioral support for people with methamphetamine use disorder. Only 5 participants were enrolled before the study was stopped early. The main goal was to track serious side effec…

This study aimed to see if a mental health app could help head and neck cancer survivors with depression. Participants would use the app for six weeks and fill out surveys. However, the study was stopped early and only enrolled one person, so no meaningful results were obtained.

This study tested a wellness program called 5Minutes4Myself for caregivers of autistic children. Participants worked with a coach to build healthy habits and used an app with reminders and mindfulness exercises. The goal was to see if the program could reduce stress and improve w…

This study tested whether using a special image-guidance system (AxiEM Stealth) helps doctors place external ventricular drains (EVDs) more accurately at the bedside compared to the usual freehand method. EVDs are thin tubes inserted into the brain's fluid-filled spaces to reliev…

This study aimed to understand how targeted muscle reinnervation (TMR) surgery affects the daily life and well-being of people who have lost a major limb. Researchers planned to follow participants for about a year using surveys and interviews. However, the study was stopped earl…